Mohamed Khairie Issa

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mohamed Khairie Issa:

Company Role Class Num Shares Value Price $ Report Date Ownership
INCYTE CORP EVP, Head of US Oncology Common Stock 66,132 $7,213,017 $109.07 07 Jan 2026 Direct
INCYTE CORP EVP, Head of US Oncology Performance Shares 21,923 15 Jul 2025 Direct
INCYTE CORP EVP, Head of US Oncology Employee Stock Option (right to buy) 14,237 16 Jan 2026 Direct

Insider Reports Filed by Mohamed Khairie Issa

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INCY INCYTE CORP 16 Jan 2026 1 $0 4 EVP, Head of US Oncology 21 Jan 2026, 16:06
INCY INCYTE CORP 06 Jan 2026 2 -$2,065,502 4 EVP, Head of US Oncology 08 Jan 2026, 16:03
INCY INCYTE CORP 15 Jul 2025 3 $0 4 EVP, Head of US Oncology 17 Jul 2025, 16:04
INCY INCYTE CORP 30 Jun 2025 1 $0 4 EVP, Head of US Oncology 02 Jul 2025, 16:42
INCY INCYTE CORP 06 Jan 2025 1 $0 4 EVP, Head of US Oncology 08 Jan 2025, 16:11
INCY INCYTE CORP 06 Jan 2025 0 $0 3 EVP, Head of US Oncology 08 Jan 2025, 16:02